Clinical Study

Home and Office Blood Pressure Monitoring in Renal Transplant Recipients

Table 1

Demographic characteristics (mean ± SD, range).

Total

Age (years) 4 8 ± 1 4 (24–79)
Body mass index (kg/m2) 2 4 . 8 ± 4 . 7 (18–44)
Gender (% males)67
Posttransplantation delay (years) (median and range)3.08 (1–31)
Office systolic blood pressure (mmHg) 1 3 9 ± 1 4 (103–181)
Office diastolic blood pressure (mmHg) 8 3 ± 1 0 (55–107)
Total cholesterol (mmol/L) 4 . 7 8 ± 0 . 9 7 (2.87–8)
LDL cholesterol (mmol/L) 2 . 4 9 ± 0 . 7 8 (1–4.33)
HDL cholesterol (mmol/L) 1 . 4 7 ± 1 . 0 9
Triglyceridemia (mmol/L) 1 . 6 8 ± 0 . 9 7 (0.5–7.3)
Diabetes (%)6
Fasting glucose level (mmol/L) 5 . 0 7 ± 1 . 0 5
HbA1c (%) 5 . 8 7 ± 0 . 0 9
Current smoker (%)5.1
Creatinine (μmol/L) 1 3 7 ± 3 9 (72–302)
Proteinuria (g/L) 0 . 1 6 ± 0 . 2 7 (0–1.9)
Microalbuminuria (mg/j) 3 2 . 3 3 ± 7 0 . 3 (0–455)
Calcemia (mmol/L) 2 . 4 ± 0 . 1 8
Patients receiving anti-hypertensive drugs (%)82.5
Number of antihypertensive drugs 1 . 5 ± 1